ABOS
Price
$1.31
Change
-$0.08 (-5.76%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
79.35M
81 days until earnings call
CRBU
Price
$1.94
Change
-$0.05 (-2.53%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
180.66M
75 days until earnings call
Interact to see
Advertisement

ABOS vs CRBU

Header iconABOS vs CRBU Comparison
Open Charts ABOS vs CRBUBanner chart's image
Acumen Pharmaceuticals
Price$1.31
Change-$0.08 (-5.76%)
Volume$3.28K
Capitalization79.35M
Caribou Biosciences
Price$1.94
Change-$0.05 (-2.53%)
Volume$4.82K
Capitalization180.66M
ABOS vs CRBU Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. CRBU commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and CRBU is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ABOS: $1.39 vs. CRBU: $1.98)
Brand notoriety: ABOS and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 68% vs. CRBU: 78%
Market capitalization -- ABOS: $79.35M vs. CRBU: $180.66M
ABOS [@Biotechnology] is valued at $79.35M. CRBU’s [@Biotechnology] market capitalization is $180.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while CRBU’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 5 bearish.
  • CRBU’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -1.42% price change this week, while CRBU (@Biotechnology) price change was +10.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

CRBU is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($181M) has a higher market cap than ABOS($79.4M). CRBU YTD gains are higher at: 24.528 vs. ABOS (-19.186). ABOS has higher annual earnings (EBITDA): -132.35M vs. CRBU (-150.76M). CRBU has more cash in the bank: 184M vs. ABOS (143M). CRBU has less debt than ABOS: CRBU (25.9M) vs ABOS (30.1M). CRBU has higher revenues than ABOS: CRBU (9.12M) vs ABOS (0).
ABOSCRBUABOS / CRBU
Capitalization79.4M181M44%
EBITDA-132.35M-150.76M88%
Gain YTD-19.18624.528-78%
P/E RatioN/AN/A-
Revenue09.12M-
Total Cash143M184M78%
Total Debt30.1M25.9M116%
TECHNICAL ANALYSIS
Technical Analysis
ABOSCRBU
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBBK43.601.60
+3.81%
Baker Boyer Bancorp
WSPOF203.110.36
+0.18%
WSP Global Inc
EDVGF2.88N/A
N/A
ENDEAVOUR GROUP LTD.
DALXF3.53-0.02
-0.62%
SPARTAN DELTA CORP.
SGTM0.04N/A
-2.11%
Sustainable Green Team, Ltd.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-4.79%
BEAM - ABOS
46%
Loosely correlated
+1.32%
KYTX - ABOS
46%
Loosely correlated
-2.38%
CRBU - ABOS
46%
Loosely correlated
-1.00%
FHTX - ABOS
45%
Loosely correlated
-2.17%
GLSI - ABOS
44%
Loosely correlated
-2.18%
More

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-1.00%
CRSP - CRBU
60%
Loosely correlated
-2.46%
BEAM - CRBU
55%
Loosely correlated
+1.32%
MGNX - CRBU
54%
Loosely correlated
-4.97%
FATE - CRBU
54%
Loosely correlated
+0.90%
RXRX - CRBU
53%
Loosely correlated
+1.24%
More